{"id":176501,"date":"2020-01-28T00:00:00","date_gmt":"2020-01-27T23:00:00","guid":{"rendered":"https:\/\/www.bcfi.be\/lajout-dinositol-a-lacide-folique-naugmente-pas-la-fertilite-chez-les-femmes-atteintes-du-syndrome-des-ovaires-polykystiques\/"},"modified":"2026-04-02T19:10:41","modified_gmt":"2026-04-02T17:10:41","slug":"lajout-dinositol-a-lacide-folique-naugmente-pas-la-fertilite-chez-les-femmes-atteintes-du-syndrome-des-ovaires-polykystiques","status":"publish","type":"post","link":"https:\/\/h.cbip.be\/fr\/lajout-dinositol-a-lacide-folique-naugmente-pas-la-fertilite-chez-les-femmes-atteintes-du-syndrome-des-ovaires-polykystiques\/","title":{"rendered":"L\u2019ajout d\u2019inositol \u00e0 l\u2019acide folique n\u2019augmente pas la fertilit\u00e9 chez les femmes atteintes du syndrome des ovaires polykystiques"},"content":{"rendered":"<div class='short-summary'>Il n\u2019y a pas de preuves que l\u2019ajout d\u2019inositol \u00e0 l\u2019acide folique permet d\u2019augmenter le taux de grossesses et de diminuer le risque de fausses couches chez les femmes atteintes du syndrome des ovaires polykystiques.<\/div>\n<p>Des compl\u00e9ments alimentaires \u00e0 base d\u2019inositol sont propos\u00e9s aux femmes atteintes du syndrome des ovaires polykystiques pour augmenter leur fertilit\u00e9. Une revue Cochrane publi\u00e9e en 2018 a \u00e9valu\u00e9 l\u2019efficacit\u00e9 et l\u2019innocuit\u00e9 de l\u2019inositol (alias myo-inositol) dans cette indication. Les \u00e9tudes disponibles sont de (tr\u00e8s) faible qualit\u00e9 m\u00e9thodologique. Il n\u2019y a donc pas de preuve que l\u2019ajout d\u2019inositol \u00e0 l\u2019acide folique permet d\u2019augmenter le taux de grossesses et de diminuer le risque de fausses couches. L\u2019effet de l\u2019acide folique n\u2019a pas \u00e9t\u00e9 \u00e9tudi\u00e9 ici et n\u2019est en soi pas clair.<br \/> \u00a0<\/p>\n<h2>Sources sp\u00e9cifiques<\/h2>\n<div class='reference'><span class='folia-referentie-tekst'>Showell MG et al.&#x002C; Inositol for subfertile women with polycystic ovary syndrome (Review). <i>The Cochrane database of Systematic Reviews<\/i>&#x002C; 2018 : 12; CD012378. DOI <a href='https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012378.pub2\/full'>10.1002\/14651858.CD012378.pub2<\/a>.<\/span><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Il n\u2019y a pas de preuves que l\u2019ajout d\u2019inositol \u00e0  [&#8230;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,61],"tags":[20213,20224],"class_list":["post-176501","post","type-post","status-publish","format-standard","hentry","category-actualites","category-2020-fr","tag-import_tags","tag-import_tags-nl"],"_links":{"self":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/176501","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/comments?post=176501"}],"version-history":[{"count":1,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/176501\/revisions"}],"predecessor-version":[{"id":179079,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/176501\/revisions\/179079"}],"wp:attachment":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/media?parent=176501"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/categories?post=176501"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/tags?post=176501"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}